Bromethenmadinone acetate (BMMA, also known as bromsuperlutin) is a
progestin medication which was developed in
Czechoslovakia
, rue, Чеськословеньско, , yi, טשעכאסלאוואקיי,
, common_name = Czechoslovakia
, life_span = 1918–19391945–1992
, p1 = Austria-Hungary
, image_p1 ...
and was described in 1970 but was never marketed.
s of BMMA include
chlormethenmadinone acetate
Chlormethenmadinone acetate (CMMA), also known as chlorsuperlutin, is a progestin medication which was developed in Czechoslovakia in the 1960s.Sterba, R. (1968). New biological application of contraceptive steroids. Endocrinologia Experimentali ...
,
melengestrol acetate
Melengestrol acetate (MLGA), sold under the brand names Heifermax and MGA among others, is a progestin medication which is used in animal reproduction. It is not approved for use in humans, and is instead used as an implantable contraceptive ...
, and
methenmadinone acetate.
See also
*
List of progestogen esters § Esters of 17α-hydroxyprogesterone derivatives
*
16-Methylene-17α-hydroxyprogesterone acetate
16-Methylene-17α-hydroxyprogesterone acetate is a progestin of the 17α-hydroxyprogesterone group which was never marketed. Given orally, it shows about 2.5-fold the progestogenic activity of parenteral progesterone in animal bioassays. It i ...
References
Abandoned drugs
Acetate esters
Bromoarenes
Enones
Diketones
Pregnanes
Progestogen esters
Progestogens
Veterinary drugs
Vinylidene compounds
{{Genito-urinary-drug-stub